0001950047-24-003027.txt : 20240410 0001950047-24-003027.hdr.sgml : 20240410 20240410162145 ACCESSION NUMBER: 0001950047-24-003027 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240410 DATE AS OF CHANGE: 20240410 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Revolution Medicines, Inc. CENTRAL INDEX KEY: 0001628171 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472029180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39219 FILM NUMBER: 24836052 BUSINESS ADDRESS: STREET 1: 700 SAGINAW DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 415-766-3638 MAIL ADDRESS: STREET 1: 700 SAGINAW DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: GOLDSMITH MARK A CENTRAL INDEX KEY: 0001246842 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 925 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 144 1 primary_doc.xml 144 0001246842 XXXXXXXX LIVE 0001628171 Revolution Medicines, Inc. 001-39219 700 Saginaw Drive Redwood City CA 94063 650-481-6801 MARK A GOLDSMITH TODSUBJECT TO STA RULES Director Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

7500 247425.00 164690408 04/10/2024 NASDAQ Common 04/10/2024 Exercise of Stock Options Issuer N 7500 04/10/2024 Cash Y 04/10/2024 12/01/2023 /s/ Mark A Goldsmith